Sequoia Financial Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-8,251
| Closed | -$271K | – | 1154 |
|
|
2023
Q4 | $271K | Buy |
8,251
+46
| +0.6% | +$1.51K | ﹤0.01% | 966 |
|
|
2023
Q3 | $229K | Hold |
8,205
| – | – | ﹤0.01% | 802 |
|
|
2023
Q2 | $280K | Sell |
8,205
-1,452
| -15% | -$49.5K | ﹤0.01% | 725 |
|
|
2023
Q1 | $290K | Sell |
9,657
-1,487
| -13% | -$44.7K | 0.01% | 640 |
|
|
2022
Q4 | $315K | Sell |
11,144
-1,578
| -12% | -$44.5K | 0.01% | 566 |
|
|
2022
Q3 | $418K | Sell |
12,722
-604
| -5% | -$19.8K | 0.01% | 321 |
|
|
2022
Q2 | $420K | Sell |
13,326
-1,004
| -7% | -$31.6K | 0.01% | 362 |
|
|
2022
Q1 | $658K | Sell |
14,330
-2,003
| -12% | -$92K | 0.02% | 304 |
|
|
2021
Q4 | $1M | Buy |
16,333
+9,653
| +145% | +$591K | 0.03% | 242 |
|
|
2021
Q3 | $499K | Sell |
6,680
-16,802
| -72% | -$1.26M | 0.05% | 154 |
|
|
2021
Q2 | $2.17M | Buy |
23,482
+2,134
| +10% | +$197K | 0.08% | 144 |
|
|
2021
Q1 | $1.89M | Buy |
21,348
+13,752
| +181% | +$1.22M | 0.08% | 134 |
|
|
2020
Q4 | $708K | Buy |
+7,596
| New | +$708K | 0.03% | 206 |
|